Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety of Multiple Formulations of an A/H1N1 Pandemic Vaccine in Healthy Subjects Aged 6 Months to 9 Years
Brief Summary: The purpose of the study is to evaluate different doses of the Influenza A/H1N1 pandemic vaccine in toddlers and children.

Primary Objectives:

* To describe the immunogenicity of the candidate vaccines after each injection.
* To describe the safety of the candidate vaccines after each injection.


Options:
A: Arm Label: CCI; Type: EXPERIMENTAL; Interventions: Biological: Cell culture-derived influenza vaccine | Arm Label: IVV; Type: EXPERIMENTAL; Interventions: Biological: Egg-derived influenza virus vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Cell culture-derived influenza vaccine; Assigned to Arm(s): CCI | Intervention Type: BIOLOGICAL; Name: Egg-derived influenza virus vaccine; Assigned to Arm(s): IVV | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: A/H1N1 Vaccine Group 1; Type: EXPERIMENTAL; Interventions: Biological: Monovalent Subvirion A/H1N1 Influenza vaccine | Arm Label: A/H1N1 Vaccine Group 2; Type: EXPERIMENTAL; Interventions: Biological: Monovalent Subvirion A/H1N1 Influenza vaccine | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Normal saline solution (placebo) | Intervention Type: BIOLOGICAL; Name: Monovalent Subvirion A/H1N1 Influenza vaccine; Assigned to Arm(s): A/H1N1 Vaccine Group 1 | Intervention Type: BIOLOGICAL; Name: Monovalent Subvirion A/H1N1 Influenza vaccine; Assigned to Arm(s): A/H1N1 Vaccine Group 2 | Intervention Type: BIOLOGICAL; Name: Normal saline solution (placebo); Assigned to Arm(s): Placebo Group
C: Arm Label: GSK1562902A non-AD F1 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses | Arm Label: GSK1562902A non-AD F2 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses | Arm Label: GSK1562902A non-AD F3 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses | Arm Label: GSK1562902A non-AD F4 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses | Arm Label: GSK1562902A AD F1 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 1 dose | Arm Label: GSK1562902A AD F2 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 1 dose | Arm Label: GSK1562902A AD F3 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 1 dose | Arm Label: GSK1562902A AD Approved F4 Primed Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 1 dose | Arm Label: Control Group; Type: EXPERIMENTAL; Interventions: Biological: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses | Intervention Type: BIOLOGICAL; Name: Pandemic influenza candidate vaccine (GSK1562902A) - 1 dose; Assigned to Arm(s): GSK1562902A AD Approved F4 Primed Group, GSK1562902A AD F1 Primed Group, GSK1562902A AD F2 Primed Group, GSK1562902A AD F3 Primed Group | Intervention Type: BIOLOGICAL; Name: Pandemic influenza candidate vaccine (GSK1562902A) - 2 doses; Assigned to Arm(s): Control Group, GSK1562902A non-AD F1 Primed Group, GSK1562902A non-AD F2 Primed Group, GSK1562902A non-AD F3 Primed Group, GSK1562902A non-AD F4 Primed Group
D: Arm Label: 6-23 months; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 2-8 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 9-17 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 18-44 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 45-60 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: >60 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Intervention Type: OTHER; Name: This is non-intervention observational study; Assigned to Arm(s): 18-44 years, 2-8 years, 45-60 years, 6-23 months, 9-17 years, >60 years

Answer: B